Prediction of clinical outcomes in patients with coronavirus disease 2019 using high-sensitive troponin I and N-terminal pro-B-type natriuretic peptide

Back

ESC Professional Premium Access

Prediction of clinical outcomes in patients with coronavirus disease 2019 using high-sensitive troponin I and N-terminal pro-B-type natriuretic peptide

Session: Cardiovascular risk assessment & COVID

Topic: Biomarkers

Speaker: Doctor M. Sano (Kobe, JP)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Madoka Sano

Kobe City Medical Center General Hospital, Kobe (Japan)

0 follower

5 more presentations in this session

Prognostic implications of cardiac 82-rubidium positron emission tomography in angina patients with no perfusion defects

Speaker: Ms M. Rauf (Copenhagen, DK)

Access

Abstract

Slides

Acute effects of COVID-19 vaccination on inflammatory, macrovasular and microvascular biomarkers

Speaker: Doctor D. Terentes-Printzios (Athens, GR)

Access

Abstract

Slides

High sensitivity troponin I and newly/recently diagnosed coronavirus-19 disease patients presenting to the emergency department: values above and below the 99th percentile predict 28 day mortality

Speaker: Professor R. Nowak (Detroit, US)

Access

Abstract

Slides

Classic and genetic cardiovascular risk burden and case-fatality from SARS-CoV-2 virus infection. The CARGENCORS study.

Speaker: Ms A. Camps-Vilaro (Madrid, ES)

Access

Abstract

Slides

Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction?

Speaker: Mr T. Gudmundsson (Gothenburg, SE)

Access

Abstract

Slides

Access the full session

Cardiovascular risk assessment & COVID

Speakers: Doctor M. Sano, Ms M. Rauf, Doctor D. Terentes-Printzios, Professor R. Nowak, Ms A. Camps-Vilaro...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources